Gene · 49
NIH grants1,192
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 1,192
Download this page as JSON| Grant | Title | ACR papers | Newest fiscal year |
|---|---|---|---|
| R01HL153161 | Pathways of Cell-Free Hemoglobin in Sickle Cell Nephropathy | 2 | 2024 |
| IK2BX004986 | Kidney Tubule Cell Function and Future Risk of Acute Kidney Injury | 1 | 2024 |
| K00CA234842 | Investigating molecular mechanism of immune response during cancer progression | 1 | 2024 |
| K08CA237619 | Improving decision-making in patients with resectable melanoma and pre-existing autoimmune disease considering immune checkpoint inhibition | 1 | 2024 |
| K23DK120811 | Non-Invasive Imaging Biomarkers to Identify a High-Risk Chronic Kidney Disease Phenotype | 1 | 2024 |
| K23HL150311 | Inflammasome Activity as a Potential Contributor to Uremic Cardiomyopathy | 1 | 2024 |
| K76AG064428 | A Novel Deprescribing Intervention for Heart Failure with Preserved Ejection Fraction (HFpEF): A Prototype for Older Adults with Multimorbidity and Polypharmacy | 1 | 2024 |
| KL2TR001444 | Mentored Career Development Program | 1 | 2024 |
| P01HL152960 | Molecular Therapies for Cystic Fibrosis Lung Disease | 1 | 2024 |
| P30ES000002 | Harvard Chan School NIEHS Center for Environmental Health | 1 | 2024 |
| R01AG068192 | Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype | 1 | 2024 |
| R01AI150358 | Next Generation Multipurpose Intravaginal Ring Technology Using Innovative CLIP 3D Printing | 1 | 2024 |
| R01AI155577 | Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox | 1 | 2024 |
| R01DK124399 | Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults | 1 | 2024 |
| R01DK125786 | Deferoxamine for the Prevention of Acute Kidney Injury | 1 | 2024 |
| R01DK126799 | Development of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 Diabetes | 1 | 2024 |
| R01ES032214 | Developmental Origins of Kidney Function in Early Life and Environmental Risks | 1 | 2024 |
| R01GM060518 | Genetic and Molecular Analyses of Human LINE-1 Retrotransposition | 1 | 2024 |
| R01GM136815 | Studies of Allostery between Multi-domain Proteins and Nucleic Acid Complexes | 1 | 2024 |
| R01HL117323 | Incorporation of a Hypertension Working Group into the Jackson Heart Study | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/grants?page=12